LEVEL 4 B02BD04

ATC

Δραστικές

NONACOG GAMMA

Φάρμακα

  • DRUGBANK - Coagulation Factor IX
  • indication:

    For treatment of hemophilia (Christmas disease).

  • pharmacology:

  • mechanism:

    Cleaves the Arg-Ile bond in Factor X to form active factor Xa leading to coagulation and clotting.

  • toxicity:

  • absorprion:

  • halflife:

    19.4 ± 5.4 hours (range from 11 to 36 hours)

  • roouteelimination:

  • volumedistribution:

  • clearance: